Biogen Inc
NASDAQ: BIIB
$164.89
-$0.90 (-0.5%)
Closing Price on November 14, 2024
BIIB Articles
The April 15 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Last Updated:
24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top exchange-traded funds for a breakdown of what they own to show how much they are lagging...
Published:
Last Updated:
The March 29 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
Biogen shares made a slight gain early on Monday after the firm made an SEC filing indicating that it will be buying back a sizable amount of stock.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included Best Buy, Biogen, China Mobile, Chipotle Mexican Grill, CNOOC, Conagra Brands, Kinder Morgan, Lumentum, Nike and Toll...
Published:
Last Updated:
Neurotrope Inc. (NASDAQ: NTRP) may be a winner by default in the battle against Alzheimer’s disease after shares of Biogen Inc. (NASDAQ: BIIB) suffered handily with the announcement that it and...
Published:
Last Updated:
Thursday was a very positive day for the broad U.S. markets. The S&P 500 and DJIA pushed higher in the session largely driven by the tech sector, although the major banks offered some resistance....
Published:
Last Updated:
Biogen shares were crushed in Thursday’s session after the firm announced that it would be discontinuing its late-stage trial for Alzheimer’s disease.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
Nightstar Therapeutics shares exploded early on Monday after it was announced that the firm would be acquired by Biogen. The transaction is expected to close by mid-year 2019.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data have been compared with the previous report, and short interest in...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, United Technologies and...
Published:
Last Updated:
Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a death cross.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included Agilent Technologies, American Water Works, Apple, Biogen, Garmin, GoDaddy, Tilray, UBS and Walmart.
Published:
Last Updated: